Current price
$0.00
0.0% today
Bullish
57
+0 vs yesterday
Last updated: 8 hr ago
JNJ is expected to hold steady with a slight upward bias near term, supported by the recent FDA approval and stable defensive demand, despite mild recent price weakness.
Global Retirement Partners LLC bought a new position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 6
Open source ↗CEO Yan discusses strategic pivot to AI-driven technology services amid industry contraction.
Open source ↗MidFirst Bank decreased its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.9% during the 2nd quarter, Holdings Channel.com reports. The firm owned 59,477 shares of the company’s st
Open source ↗Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc., Abbott Laboratories, AbbVie, Pfizer, and Gilead Sciences are the seven Pharmaceutical stocks to watch today, according to MarketBeat’s stoc
Open source ↗MidFirst Bank decreased its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.9% during the 2nd quarter, Holdings Channel.com reports. The firm owned 59,477 shares of the company’s st
Open source ↗Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc., Abbott Laboratories, AbbVie, Pfizer, and Gilead Sciences are the seven Pharmaceutical stocks to watch today, according to MarketBeat’s stoc
Open source ↗